GlassScriptPhysician profile
Duo Xu
NPI 1992117014
$16,481.68
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,476 · 2020: $350 · 2022: $2,730 · 2023: $310 · 2024: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $370 · Travel and Lodging: $56.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $369.72 |
| Travel and Lodging | $56.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $7,596.65 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $4,000.00 | 2024 | Quatera 700, Iolmaster 700, Veracity Surgical |
| Apellis Pharmaceuticals, INC. | $2,730.00 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $806.34 | 2019 | |
| Alimera Sciences, INC. | $472.66 | 2019-2020 | |
| Dutch Ophthalmic, USA | $288.86 | 2019-2024 | Eva, Combined Machine, Tissueblue |
| Allergan, INC. | $244.74 | 2019 | |
| Bausch & Lomb Americas INC. | $119.87 | 2023 | Visudyne, Xipere, Stellaris |
| Regeneron Healthcare Solutions, INC. | $109.51 | 2019 | |
| Carl Zeiss Meditec, INC. | $59.82 | 2019 | |
| Genentech USA, INC. | $53.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duo Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.